Clinical trial of mesenchymal stem cell mobilization factor KOI2 in epidermolysis bullosa patients
Not Applicable
- Conditions
- epidermolysis bullosa
- Registration Number
- JPRN-UMIN000029962
- Lead Sponsor
- Osaka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Epidermolysis bullosa other than malnutrition type (2) Urine pregnancy test is positive (female only) at screening visit (3) Breast feeding female patient (4) HIV, HBs, HCV positive at screening (5) A subject who participated in other clinical trials within 90 days and received a clinical trial drug (including a placebo) (6) A subject who is participating in any other clinical trials. (7) A subject whose liver dysfunction data match the predefined exclusion standard (8) A subject who has acute worsening of epidermolysis bullosa (such as tracheal/esophageal stenosis, acute nephritis) (9) Ineligible by other reasons judged by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method